4.4 Review

Suppressive Influences in the Immune Response to Cancer

Journal

JOURNAL OF IMMUNOTHERAPY
Volume 32, Issue 1, Pages 1-11

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CJI.0b013e3181837276

Keywords

tumor immunology; immunotherapy; tumor immune escape

Funding

  1. Pfizer

Ask authors/readers for more resources

Although much evidence has been gathered demonstrating that. immune effectors can play a significant role in controlling tumor growth under natural conditions or in response to therapeutic manipulation, it is clear that malignant cells do evade immune surveillance in most cases. Considering that anticancer active specific immunotherapy seems to have reached a plateau Of results and that currently no vaccination regimen is indicated a,,, a standard anticancer therapy, the dissection of the molecular events underlying tumor immune escape is the necessary condition to make anticancer vaccines a therapeutic weapon effective enough to be implemented ill the routine clinical setting. Recent years have witnessed significant advances in our understanding of the molecular mechanisms underlying tumor immune escape. These mechanistic insights are fostering the development of rationally designed therapeutics aimed to revert the immunosuppressive Circuits that undermine an effective antitumor immune response. In this review, the best characterized mechanisms that allow cancer cells to evade immune surveillance are overviewed and the most debated controversies constellating this complex field are highlighted.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available